ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

The Challenges of Research in Immunotherapy – Mesothelioma.com (blog)

The Challenges of Research in ImmunotherapyMesothelioma.com (blog)Cancer research has made great advancements in recent years with emerging treatments like immunotherapy. Harnessing the immune system in different ways to better combat cancer has proven… Continue reading

2017-06-16 Michael Zand NEWS

‘Living drugs’ offer promise for blood cancer patients – Honolulu Star-Advertiser

Continue reading

2017-06-16 Michael Zand NEWS

Merck granted its first CRISPR patent in Australia – Life Sciences Intellectual Property Review (subscription)

Life Sciences Intellectual Property Review (subscription)Merck granted its first CRISPR patent in AustraliaLife Sciences Intellectual Property Review (subscription)On Wednesday, June 14, Merck issued a press release explaining that the office had grant… Continue reading

2017-06-16 Michael Zand NEWS

Banks targets embryonic stem cell research funding – Fort Wayne Journal Gazette


Honolulu Star-Advertiser

‘Living drugs’ offer promise for blood cancer patients
Honolulu Star-Advertiser
“It shows the unbelievable power of your immune system,” said Dr. David Maloney, Fred Hutch’s medical director for cellular immunotherapy, who treated Shefveland with a type called CAR–T cells. “We’re talking, really, patients who have no other options …

Continue reading

2017-06-16 Michael Zand NEWS

ISSCR 2017: Researchers say vitamin C keeps epigenome as well as stem cells happy – BioWorld Online


Fort Wayne Journal Gazette

Banks targets embryonic stem cell research funding
Fort Wayne Journal Gazette
Rep. Jim Banks, R-3rd, introduced legislation Thursday that would prevent the use of federal funds for stem cell research involving human embryos. Banks’ bill would direct the U.S. Department of Health and Human Services to give priority to medical …

Continue reading

2017-06-16 Michael Zand NEWS

Bone marrow mesenchymal stem cell repair of cyclophosphamide-induced ovarian insufficiency in a mouse model – Dove Medical Press

Dove Medical PressBone marrow mesenchymal stem cell repair of cyclophosphamide-induced ovarian insufficiency in a mouse modelDove Medical PressObjective: Attempting in vivo healing of cyclophosphamide-induced ovarian insufficiency in a mouse model usin… Continue reading

2017-06-16 Michael Zand NEWS

Bone marrow mesenchymal stem cell repair of cyclophosphamide-induced ovarian insufficiency in a mouse model – Dove Medical Press

Dove Medical PressBone marrow mesenchymal stem cell repair of cyclophosphamide-induced ovarian insufficiency in a mouse modelDove Medical PressObjective: Attempting in vivo healing of cyclophosphamide-induced ovarian insufficiency in a mouse model usin… Continue reading

2017-06-16 Michael Zand NEWS

Nanobiotix: New Translational Data Presented at ASTRO, NCI AND … – Business Wire (press release)

ISSCR 2017: Researchers say vitamin C keeps epigenome as well as stem cells happy
BioWorld Online
BOSTON – At the Thursday morning plenary of the annual meeting of the International Society for Stem Cell Research (ISSCR), those who came into the plenary room carrying their morning cup of orange juice turned out to be taking care of their own stem …

and more »

Continue reading

2017-06-15 Michael Zand NEWS
  • 1
  • …
  • 1,610
  • 1,611
  • 1,612
  • 1,613
  • 1,614
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Business Wire (press release)

Nanobiotix: New Translational Data Presented at ASTRO, NCI AND …
Business Wire (press release)
Regulatory News: NANOBIOTIX (Euronext: NANO – ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering new approaches to the t.

and more »